INS and diabetes mellitus: Unlike insulin, it does not undergo hepatic first pass metabolism, has a longer half‐life, and has been recognized as a more stable and accurate marker of endogenous insulin secretion.12–14 However, there is limited data on the clinical and epidemiological value of C‐peptide measurement as a marker of insulin resistance, especially in individuals without known diabetes mellitus.